Nine states established the Southern African Development Coordinating Conference (SADCC), a precursor to SADC that later became a key platform for regional cooperation, including in health and disease control.
Medical reports identified the first reported cases of HIV-1 infection in South Africa, marking the beginning of documented HIV presence in the country and foreshadowing a rapidly expanding regional epidemic.
The first reported HIV case in Eswatini (then Swaziland) appeared in local reporting, an early indicator of HIV’s growing footprint in Southern Africa during the 1980s.
The U.S. FDA approved zidovudine (AZT) as the first antiretroviral drug for AIDS, an early treatment breakthrough that later influenced treatment debates and access efforts worldwide, including in Southern Africa.
SADCC transformed into the Southern African Development Community (SADC), strengthening regional institutions that would later support multi-country coordination relevant to HIV/AIDS responses.
The UN created UNAIDS (established in 1994; operational from January 1996) to coordinate the global HIV response—an important shift toward sustained, multi-agency support affecting Southern African strategies and financing.
The Treatment Action Campaign (TAC) was launched to fight for equitable access to HIV treatment and to press the state to expand evidence-based prevention and care—becoming a pivotal civil-society actor in Southern Africa’s HIV response.
The Durban Declaration—published to coincide with AIDS 2000—affirmed that HIV causes AIDS, countering denialism that affected public discourse and policy in South Africa at a critical moment in the epidemic.
The XIII International AIDS Conference (AIDS 2000) in Durban spotlighted the severity of the epidemic in Southern Africa and intensified global attention on treatment access, prevention, and human rights in the region.
The Global Fund to Fight AIDS, Tuberculosis and Malaria was formally established, creating a major new multilateral financing mechanism that substantially expanded resources available for HIV programs across Southern Africa.
A South African High Court ordered the government to provide antiretroviral drugs (notably nevirapine) to reduce mother-to-child transmission, reflecting escalating legal and civic pressure for wider public-sector access.
South Africa’s Constitutional Court ruled in Minister of Health v Treatment Action Campaign, a landmark decision compelling the state to take reasonable measures to expand access to medicines to prevent mother-to-child HIV transmission.
The South African Cabinet approved in principle an Operational Plan for Comprehensive HIV and AIDS Treatment and Care, directing implementation of public-sector antiretroviral treatment as part of a comprehensive strategy.
Following Cabinet approval and planning, South Africa began rolling out free antiretroviral treatment through the public health system (initially at selected major hospitals), a turning point in treatment access at scale.
HIV/AIDS Epidemic and Response in Southern Africa (1980–2010)
